trans-Cyclohexane-1,2-diol

Name: trans-Cyclohexane-1,2-diol
Brand: MedChemExpress
SKU: HY-W010514
Rating: 4.5 (1 reviews)

Cat. No.: HY-W010514 Purity: 99.74%: FAQs
Data Sheet
SDS

COA
Handling Instructions Technical Support

trans-Cyclohexane-1,2-diol (TCHD) is a transient dilator of the nuclear pore complex (NPC). By interacting with the hydrophobic core (FG nucleoporin) of the NPC, trans-Cyclohexane-1,2-diol can disrupt the NPC structure and reversibly increase the permeability of the nuclear pore, allowing macromolecules larger than 40 kDa (such as plasmid DNA) to enter the cell nucleus by passive diffusion, thereby enhancing the nuclear import efficiency of non-viral vectors. trans-Cyclohexane-1,2-diol can improve the efficiency of in vitro electrotransfection or lipid-mediated gene transfection, especially significantly increasing gene expression in differentiated airway epithelial cells.

For research use only. We do not sell to patients.

trans-Cyclohexane-1,2-diol Chemical Structure

CAS No. : 1460-57-7

Size	Stock	Quantity

Free Sample (0.1 - 0.5 mg)	Apply Now
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO ready for reconstitution	In-stock	Estimated Time of Arrival: December 31
Solution
10 mM * 1 mL in DMSO	In-stock	Estimated Time of Arrival: December 31
Solid
100 mg	In-stock	Estimated Time of Arrival: December 31
1 g	In-stock	Estimated Time of Arrival: December 31
5 g	Get quote
10 g	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

In Vitro

Lipid-mediated transfection experiment:
trans-Cyclohexane-1,2-diol (0.5%-2%; 1 h) dose-dependently increases Lipofectamine- and GL67A-mediated luciferase gene expression in 293T cells. Concentrations of ≥1.5% results in 80% cell protein loss, indicating significant cytotoxicity^[1].
Electroporation experiment: trans-Cyclohexane-1,2-diol (1%; 10-30 min) significantly increases GFP/Tomato gene expression in both B16F10 and CHO cells (1.5-2.5-fold increase in fluorescence intensity), and cell viability is not inhibited^[2].

Trans-Cyclohexane-1,2-diol (TCHD) In Vitro Electroporation Protocol^[2]
Materials:
(1) B16F10 mouse melanoma cells and CHO (Chinese hamster ovary) cells were cultured to 70% confluence, trypsinized and resuspended in electroporation buffer (PB: 10 mM K₂HPO₄/KH₂PO₄, 1 mM MgCl₂, 250 mM sucrose, pH 7.4, cell concentration adjusted to 5×10⁶ cells/mL.
(2) Plasmid DNA: pCMV-eGFP-C1 or pCMV-CpGfree-tdTomato, concentration 20 μg/mL (dissolved in electroporation buffer).
(3) Reagents: TCHD solution: 1% w/v (mass/volume) , dissolved in electroporation buffer, and sterilized by filtration. Fetal bovine serum (FBS), crystal violet staining solution, PBS buffer.
(4) Equipment: electroporator (such as Electrocell S20), parallel stainless steel electrodes (spacing 0.4 cm), fluorescence microscope, flow cytometer.
Operation steps
Cell preparation: Collect cells in logarithmic growth phase, wash twice with PB buffer after centrifugation, resuspend cells to 5×10⁶ cells/mL, add plasmid DNA to a final concentration of 20 μg/mL, and mix well.
Electrotransfection parameter setting:
Low field long pulse (LF-LP): 6 square wave pulses, 600 V/cm, 5 ms pulse duration, frequency 1 Hz.
High field short pulse (HF-SP): 4 square wave pulses, 1200 V/cm, 100 μs pulse duration, frequency 1 Hz. 100 μL of cell-DNA suspension was added to the electrode gap and the electric pulses were applied at room temperature.
TCHD treatment:
Immediately after the pulse: Immediately after the pulse, 20 μL of 1% TCHD solution (final concentration approximately 0.18% w/v) was added and gently mixed. After incubation for 10 minutes after the pulse, another 20 μL of 1% TCHD solution was added. Both treatments were incubated at 37°C for 10, 20, or 30 minutes, and the control group was added with an equal volume of electroporation buffer.
Cell culture:
After the incubation period, the cells were transferred to complete medium (DMEM or EMEM) containing 10% FBS, seeded in 12-well plates, and cultured at 37°C, 5% CO2 for 24 hours.
Detection and analysis:
(1) After 24 hours, cell viability was detected by crystal violet staining. The culture medium was discarded, the cells were washed with PBS, and 0.1% crystal violet solution was added for staining for 20 minutes. After dissolving in 10% acetic acid, the absorbance at 595 nm was measured.
(2) Flow cytometry is used to detect the percentage of GFP/Tomato positive cells and the mean fluorescence intensity (MFI). The cells were trypsinized, washed with PBS, and resuspended in FACS buffer (containing 2.5% FBS) and analyzed by flow cytometry.
(3) After fixing the cells, the distribution of fluorescent protein expression was observed using a fluorescence microscope (GFP excitation light 480/40 nm, emission light 527/40 nm; Tomato excitation light 560/40 nm, emission light 630/75 nm).
Key parameters and optimized TCHD concentration:
The optimal final concentration is 0.18% w/v (i.e., 1% stock solution is added at a volume ratio of 1:6). Higher concentrations (such as 2%) may cause cytotoxicity.

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Molecular Weight

116.16

Formula

C₆H₁₂O₂

CAS No.

1460-57-7

Appearance

Solid

Color

White to off-white

SMILES

O[C@H]1[C@H](O)CCCC1

Structure Classification

Others

Initial Source

Endogenous metabolite

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Store at room temperature 3 years

In solvent	-80°C	2 years
	-20°C	1 year

Solvent & Solubility

In Vitro:

H₂O : 100 mg/mL (860.88 mM; Need ultrasonic)

DMSO : 50 mg/mL (430.44 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	8.6088 mL	43.0441 mL	86.0882 mL
5 mM	1.7218 mL	8.6088 mL	17.2176 mL
10 mM	0.8609 mL	4.3044 mL	8.6088 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

Concentration _(start)

Volume _(start)

Concentration _(final)

Volume _(final)

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (21.52 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (21.52 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil
Solubility: ≥ 2.5 mg/mL (21.52 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: PBS
Solubility: 110 mg/mL (946.97 mM); Clear solution; Need ultrasonic

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).

Purity & Documentation

Purity: 99.94%

Select Batch:

Data Sheet (280 KB) SDS (393 KB)

COA (251 KB) HNMR (145 KB) GC (80 KB)

Handling Instructions (2659 KB)

References

[1]. Griesenbach U, et al. Assessment of the nuclear pore dilating agent trans-cyclohexane-1,2-diol in differentiated airway epithelium. J Gene Med. 2012 Jul;14(7):491-500. [Content Brief]

[2]. Pasquet L, et al. Post-pulse addition of trans-cyclohexane-1,2-diol improves electrotransfer mediated gene expression in mammalian cells. Biochem Biophys Rep. 2016 Jul 17;7:287-294. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO / H₂O	1 mM	8.6088 mL	43.0441 mL	86.0882 mL	215.2204 mL
	5 mM	1.7218 mL	8.6088 mL	17.2176 mL	43.0441 mL
	10 mM	0.8609 mL	4.3044 mL	8.6088 mL	21.5220 mL
	15 mM	0.5739 mL	2.8696 mL	5.7392 mL	14.3480 mL
	20 mM	0.4304 mL	2.1522 mL	4.3044 mL	10.7610 mL
	25 mM	0.3444 mL	1.7218 mL	3.4435 mL	8.6088 mL
	30 mM	0.2870 mL	1.4348 mL	2.8696 mL	7.1740 mL
	40 mM	0.2152 mL	1.0761 mL	2.1522 mL	5.3805 mL
	50 mM	0.1722 mL	0.8609 mL	1.7218 mL	4.3044 mL
	60 mM	0.1435 mL	0.7174 mL	1.4348 mL	3.5870 mL
	80 mM	0.1076 mL	0.5381 mL	1.0761 mL	2.6903 mL
	100 mM	0.0861 mL	0.4304 mL	0.8609 mL	2.1522 mL

* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.